Home Cart 0 Sign in  
X

[ CAS No. 367-23-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 367-23-7
Chemical Structure| 367-23-7
Chemical Structure| 367-23-7
Structure of 367-23-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 367-23-7 ]

Related Doc. of [ 367-23-7 ]

Alternatived Products of [ 367-23-7 ]

Product Details of [ 367-23-7 ]

CAS No. :367-23-7 MDL No. :MFCD00000305
Formula : C6H3F3 Boiling Point : -
Linear Structure Formula :- InChI Key :PEBWOGPSYUIOBP-UHFFFAOYSA-N
M.W : 132.08 Pubchem ID :67773
Synonyms :

Calculated chemistry of [ 367-23-7 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 26.32
TPSA : 0.0 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.32 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.84
Log Po/w (XLOGP3) : 2.52
Log Po/w (WLOGP) : 3.36
Log Po/w (MLOGP) : 3.58
Log Po/w (SILICOS-IT) : 3.13
Consensus Log Po/w : 2.89

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.74
Solubility : 0.24 mg/ml ; 0.00182 mol/l
Class : Soluble
Log S (Ali) : -2.17
Solubility : 0.901 mg/ml ; 0.00682 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.2
Solubility : 0.0835 mg/ml ; 0.000632 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.23

Safety of [ 367-23-7 ]

Signal Word:Danger Class:3
Precautionary Statements:P210-P233-P235-P240-P241-P242-P243-P260-P261-P264-P271-P280-P302+P352-P303+P361+P353-P304-P304+P340-P305+P351+P338-P312-P321-P332+P313-P337+P313-P340-P362-P370+P378-P403-P403+P233-P403+P235-P405-P501 UN#:1993
Hazard Statements:H225-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 367-23-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 367-23-7 ]
  • Downstream synthetic route of [ 367-23-7 ]

[ 367-23-7 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 367-23-7 ]
  • [ 2991-28-8 ]
Reference: [1] Journal of Physical Chemistry A, 2000, vol. 104, # 2, p. 352 - 361
  • 2
  • [ 367-23-7 ]
  • [ 327-52-6 ]
YieldReaction ConditionsOperation in experiment
98.7% at 20℃; for 2 h; To a 500-mL three-necked flask, 100 g of 1,2,4-trifluorobenzene and 3 g of tin tetrachloride-polystyrene composite were added. Glacial acetic acid was used as a reaction solvent. 127 mL of liquid bromine was slowly added dropwise at room temperature. Reaction 2h, TLC monitoring raw material reaction is complete, vacuum evaporate glacial acetic acid, add 500mL of chloroform, and then wash the organic phase with a concentration of 3percent diluted hydrochloric acid, add saturated sodium sulfite solution to remove the bromine in the organic phase, and wash sequentially, After washing with saturated saline and distilling off the solvent, 158 g of the product, trifluorobromobenzene, was obtained in a yield of 98.7percent, and the purity by gas chromatography was 99.6percent.
Reference: [1] Patent: CN107673951, 2018, A, . Location in patent: Paragraph 0015; 0016; 0017; 0018
[2] Journal of the American Chemical Society, 1951, vol. 73, p. 153[3] Journal of the American Chemical Society, 1959, vol. 81, p. 94,98
  • 3
  • [ 540-36-3 ]
  • [ 367-23-7 ]
  • [ 2713-31-7 ]
  • [ 703-16-2 ]
  • [ 22060-77-1 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1998, # 11, p. 1807 - 1811
  • 4
  • [ 367-23-7 ]
  • [ 17533-08-3 ]
Reference: [1] Nucleosides, Nucleotides and Nucleic Acids, 2001, vol. 20, # 1-2, p. 11 - 40
[2] Australian Journal of Chemistry, 1979, vol. 32, p. 737 - 753
  • 5
  • [ 367-23-7 ]
  • [ 66684-57-9 ]
Reference: [1] Journal of Organic Chemistry, 1995, vol. 60, # 22, p. 7348 - 7350
  • 6
  • [ 367-23-7 ]
  • [ 2105-61-5 ]
Reference: [1] Chemische Berichte, 1951, vol. 84, p. 101,108
[2] Journal of the American Chemical Society, 1951, vol. 73, p. 153[3] Journal of the American Chemical Society, 1959, vol. 81, p. 94,98
  • 7
  • [ 124-38-9 ]
  • [ 367-23-7 ]
  • [ 2358-29-4 ]
Reference: [1] Journal of the American Chemical Society, 2010, vol. 132, # 26, p. 8858 - 8859
[2] Angewandte Chemie - International Edition, 2010, vol. 49, # 46, p. 8674 - 8677
[3] Journal of Physical Chemistry A, 2000, vol. 104, # 2, p. 352 - 361
  • 8
  • [ 367-23-7 ]
  • [ 98349-24-7 ]
Reference: [1] Journal of Medicinal Chemistry, 1991, vol. 34, # 1, p. 168 - 174
Same Skeleton Products
Historical Records